$22MSeries C, 5 March 2026
Strengthens manufacturing, quality systems and regulatory work for ExaStim
- Amount
- $22M
- Stage
- Series C
- Announced
- 5 March 2026
- Lead
- Catcher Technology
- Use of funds
- Strengthens manufacturing, quality systems and regulatory work for ExaStim
- Checked
- Announced by the company
- Sources
- ANEUVO secures Series C funding globenewswire.com
ANEUVO secures Series C funding globenewswire.com